Why Is Jaguar Health (JAGX) Stock Down 55% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Jaguar Health stock is down on Tuesday as JAGX investors react to failed results from a Phase 3 clinical trial of crofelemer.

The post Why Is Jaguar Health (JAGX) Stock Down 55% Today? appeared first on InvestorPlace.

• Legendary Investor Predicts: “Forget AI... THIS Technology Is the Future”